Profile
Rittenhouse Ventures is a Philadelphia-based venture capital firm founded in 2008. The firm specializes in investing in emerging-growth technology businesses, particularly in the healthcare technology, AI, digital media monetization, and precision pharmacy sectors. With a team of seasoned professionals, Rittenhouse Ventures offers strategic, operational, and financial support to entrepreneurs, partnering with them from investment to exit. The firm is known for its capital-efficient growth strategies and deep domain expertise.
Rittenhouse Ventures focuses on B2B software, healthcare, pharmaceutical technology, financial services, human resources, and business services sectors. They typically invest in companies at the venture capital stage, providing right-sized investments to minimize dilution and maximize growth. The firm operates primarily in North America, leveraging strategic and regional partnerships to enhance its investment approach. Although specific AUM figures are not disclosed, Rittenhouse Ventures emphasizes its capital-efficient strategies.
Notable investments in their portfolio include S2N Health - commercial intelligence for MedTech, StationMD - telemedicine software services, Smarter Technologies - AI-driven clinical documentation solutions, Piano Software - digital media monetization and analytics, High QA - manufacturing quality management, Bites - AI-powered microlearning, and GalenusCare - precision pharmacy and medication management.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.